Analysis Metabolite Name Measured Value Units Feeding:Fed | Group
Reversed phase NEGATIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-20181Peak areaHCR-AL
Reversed phase NEGATIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-21158Peak areaHCR-CR
Reversed phase NEGATIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-21362Peak areaLCR-CR
Reversed phase NEGATIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-21562Peak areaHCR-CR
Reversed phase NEGATIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-21568Peak areaHCR-CR
Reversed phase NEGATIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-22364Peak areaHCR-CR
Reversed phase NEGATIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-22920Peak areaHCR-CR
Reversed phase NEGATIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-23221Peak areaHCR-AL
Reversed phase NEGATIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-23431Peak areaHCR-CR
Reversed phase NEGATIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-23626Peak areaHCR-AL
Reversed phase NEGATIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-24235Peak areaLCR-AL
Reversed phase NEGATIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-24273Peak areaHCR-CR
Reversed phase NEGATIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-25053Peak areaHCR-CR
Reversed phase NEGATIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-25419Peak areaHCR-AL
Reversed phase NEGATIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-25561Peak areaHCR-CR
Reversed phase NEGATIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-26397Peak areaLCR-CR
Reversed phase NEGATIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-26501Peak areaHCR-CR
Reversed phase NEGATIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-26568Peak areaLCR-CR
Reversed phase NEGATIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-26842Peak areaLCR-CR
Reversed phase NEGATIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-27060Peak areaLCR-AL
Reversed phase NEGATIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-27106Peak areaLCR-CR
Reversed phase NEGATIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-27206Peak areaHCR-AL
Reversed phase NEGATIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-27210Peak areaLCR-CR
Reversed phase NEGATIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-27637Peak areaHCR-AL
Reversed phase NEGATIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-28419Peak areaHCR-AL
Reversed phase NEGATIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-28431Peak areaHCR-CR
Reversed phase NEGATIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-28668Peak areaLCR-AL
Reversed phase NEGATIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-29098Peak areaHCR-CR
Reversed phase NEGATIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-29605Peak areaLCR-AL
Reversed phase NEGATIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-29843Peak areaLCR-AL
Reversed phase NEGATIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-29889Peak areaHCR-AL
Reversed phase NEGATIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-30167Peak areaHCR-AL
Reversed phase NEGATIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-30412Peak areaLCR-CR
Reversed phase NEGATIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-31338Peak areaLCR-AL
Reversed phase NEGATIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-32613Peak areaLCR-CR
Reversed phase NEGATIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-32615Peak areaLCR-AL
Reversed phase NEGATIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-33601Peak areaLCR-CR
Reversed phase NEGATIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-33693Peak areaLCR-CR
Reversed phase NEGATIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-33726Peak areaLCR-AL
Reversed phase NEGATIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-34467Peak areaLCR-AL
Reversed phase NEGATIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-34723Peak areaHCR-AL
Reversed phase NEGATIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-35412Peak areaLCR-AL
Reversed phase NEGATIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-37452Peak areaLCR-AL
Reversed phase NEGATIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-40251Peak areaLCR-CR
Reversed phase NEGATIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-41105Peak areaLCR-CR
Reversed phase NEGATIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)-41879Peak areaLCR-AL
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+5410Peak areaLCR-CR
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+9833Peak areaHCR-AL
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+10123Peak areaHCR-CR
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+11787Peak areaLCR-AL
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+11848Peak areaHCR-CR
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+11904Peak areaLCR-AL
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+12063Peak areaLCR-CR
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+12084Peak areaHCR-CR
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+13049Peak areaLCR-CR
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+13117Peak areaHCR-CR
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+13654Peak areaHCR-AL
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+14724Peak areaLCR-CR
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+14822Peak areaHCR-CR
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+15392Peak areaHCR-CR
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+15852Peak areaLCR-AL
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+17228Peak areaHCR-AL
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+18576Peak areaHCR-AL
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+18866Peak areaHCR-CR
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+19189Peak areaHCR-AL
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+19206Peak areaLCR-CR
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+19211Peak areaLCR-AL
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+19299Peak areaLCR-CR
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+19960Peak areaHCR-AL
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+20628Peak areaHCR-CR
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+21098Peak areaHCR-AL
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+21317Peak areaLCR-AL
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+23546Peak areaLCR-CR
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+23612Peak areaLCR-CR
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+25027Peak areaLCR-CR
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+25770Peak areaLCR-AL
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+26043Peak areaLCR-AL
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+27444Peak areaLCR-AL
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+27591Peak areaLCR-CR
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+29250Peak areaHCR-CR
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+32998Peak areaLCR-AL
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+33371Peak areaLCR-AL
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+35478Peak areaLCR-AL
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+35613Peak areaLCR-CR
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+36032Peak areaLCR-AL
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+Peak areaHCR-CR
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+Peak areaHCR-AL
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+Peak areaHCR-CR
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+4430Peak areaLCR-CR
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+6673Peak areaLCR-CR
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+7386Peak areaHCR-CR
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+8110Peak areaLCR-AL
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+8327Peak areaHCR-AL
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+9067Peak areaHCR-CR
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+9439Peak areaLCR-CR
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+10800Peak areaHCR-AL
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+10984Peak areaHCR-AL
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+11402Peak areaHCR-AL
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+11746Peak areaHCR-AL
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+11759Peak areaHCR-CR
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+12149Peak areaHCR-CR
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+12441Peak areaHCR-AL
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+12524Peak areaLCR-CR
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+12792Peak areaHCR-CR
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+13184Peak areaLCR-CR
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+13218Peak areaHCR-CR
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+13566Peak areaLCR-AL
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+13973Peak areaHCR-CR
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+14272Peak areaHCR-CR
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+14366Peak areaLCR-AL
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+14390Peak areaHCR-AL
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+14466Peak areaHCR-CR
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+14468Peak areaLCR-AL
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+14795Peak areaLCR-AL
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+14815Peak areaLCR-CR
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+15222Peak areaLCR-AL
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+15382Peak areaLCR-CR
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+15517Peak areaHCR-CR
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+15986Peak areaLCR-AL
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+16167Peak areaLCR-CR
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+16393Peak areaLCR-CR
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+16498Peak areaLCR-CR
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+17913Peak areaLCR-AL
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+17975Peak areaLCR-AL
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+18233Peak areaLCR-AL
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+18334Peak areaLCR-CR
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+20923Peak areaHCR-CR
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+21279Peak areaLCR-AL
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+21934Peak areaLCR-AL
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+Peak areaHCR-CR
Reversed phase POSITIVE ION MODEN-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+Peak areaHCR-AL

Return to search page
  logo